Suppression of streptozotocin-induced type-1 diabetes in mice by radon inhalation

Y. Nishiyama, T. Kataoka, J. Teraoka, A. Sakoda, H. Tanaka, Y. Ishimori, F. Mitsunobu, T. Taguchi, K. Yamaoka

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

We examined the protective effect of radon inhalation on streptozotocin (STZ)-induced type-1 diabetes in mice. Mice inhaled radon at concentrations of 1000, 2500, and 5500 Bq/m3 for 24 hours before STZ administration. STZ administration induced characteristics of type-1 diabetes such as hyperglycemia and hypoinsulinemia; however, radon inhalation at doses of 1000 and 5500 Bq/m3 significantly suppressed the elevation of blood glucose in diabetic mice. Serum insulin was significantly higher in mice pre-treated with radon at a dose of 1000 Bq/m3 than in mice treated with a sham. In addition, superoxide dismutase activities and total glutathione contents were significantly higher and lipid peroxide was significantly lower in mice pre-treated with radon at doses of 1000 and 5500 Bq/m3 than in mice treated with a sham. These results were consistent with the result that radon inhalation at 1000 and 5500 Bq/m3 suppressed hyperglycemia. These findings suggested that radon inhalation suppressed STZ-induced type-1 diabetes through the enhancement of antioxidative functions in the pancreas.

Original languageEnglish
Pages (from-to)57-66
Number of pages10
JournalPhysiological Research
Volume62
Issue number1
Publication statusPublished - 2013

Keywords

  • Antioxidative function
  • Radon inhalation
  • Streptozotocin
  • Type-1 diabetes

ASJC Scopus subject areas

  • Physiology

Fingerprint Dive into the research topics of 'Suppression of streptozotocin-induced type-1 diabetes in mice by radon inhalation'. Together they form a unique fingerprint.

  • Cite this